Marshall Wace North America’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-53,132
Closed -$187K 1570
2020
Q1
$187K Sell
53,132
-19,547
-27% -$166K ﹤0.01% 904
2019
Q4
$767K Buy
72,679
+55,854
+332% +$496K ﹤0.01% 754
2019
Q3
$188K Buy
+16,825
New +$199K ﹤0.01% 970
2018
Q2
Sell
-31,146
Closed -$480K 1791
2018
Q1
$480K Sell
31,146
-148,221
-83% -$2.48M ﹤0.01% 1163
2017
Q4
$2.93M Buy
+179,367
New +$3.47M 0.02% 729
2017
Q3
Sell
-43,211
Closed -$1.21M 1575
2017
Q2
$1.21M Sell
43,211
-16,138
-27% -$446K 0.01% 882
2017
Q1
$1.84M Buy
+59,349
New +$1.68M 0.01% 596
2013
Q4
$987K Buy
+29,892
New +$932K 0.02% 398

Other funds holding DBD

Marshall Wace North America's DBD Position: Q2 2020 in Review

Marshall Wace North America sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2020, closing a stake of 53,132 shares — an estimated $187K sold.

Marshall Wace North America first reported a position in DBD in Q4 2013 and held it in 8 quarters. The position peaked at $2.93M in Q4 2017. 178 funds tracked by Wall St. Rank hold DBD as of Q2 2020.

  • Marshall Wace North America reported no remaining Diebold Nixdorf Incorporated position as of Q2 2020 after selling out during the quarter.
  • Marshall Wace North America sold 53,132 Diebold Nixdorf Incorporated shares in Q2 2020, an estimated $187K.
  • Marshall Wace North America first reported a position in Diebold Nixdorf Incorporated in Q4 2013 and held it in 8 quarters.
  • Marshall Wace North America's Diebold Nixdorf Incorporated position peaked at $2.93M in Q4 2017.
  • 178 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2020.

Based on Marshall Wace North America's 13F filing for Q2 2020, filed 13 Aug 2020.